Insider Transactions in Q3 2024 at Eliem Therapeutics, Inc. (ELYM)
Insider Transaction List (Q3 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 20
2024
|
Emily Pimblett CHIEF ACCOUNTING OFFICER |
SELL
Open market or private sale
|
Direct |
1,191
-6.81%
|
$9,528
$8.12 P/Share
|
|
Sep 18
2024
|
Emily Pimblett CHIEF ACCOUNTING OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+36.35%
|
-
|
|
Jul 22
2024
|
Valerie Morisset EVP, R&D AND CSO |
SELL
Open market or private sale
|
Direct |
69,005
-43.9%
|
$552,040
$8.03 P/Share
|
|
Jul 19
2024
|
Valerie Morisset EVP, R&D AND CSO |
SELL
Open market or private sale
|
Direct |
60,201
-19.81%
|
$421,407
$7.17 P/Share
|
|
Jul 18
2024
|
Valerie Morisset EVP, R&D AND CSO |
SELL
Open market or private sale
|
Direct |
38,576
-19.38%
|
$231,456
$6.93 P/Share
|
|
Jul 17
2024
|
Valerie Morisset EVP, R&D AND CSO |
SELL
Open market or private sale
|
Direct |
3,207
-1.59%
|
$19,242
$6.91 P/Share
|
|
Jul 16
2024
|
Valerie Morisset EVP, R&D AND CSO |
SELL
Open market or private sale
|
Direct |
50,000
-19.82%
|
$350,000
$7.13 P/Share
|
|
Jul 15
2024
|
Valerie Morisset EVP, R&D AND CSO |
SELL
Open market or private sale
|
Direct |
42,377
-14.38%
|
$296,639
$7.01 P/Share
|
|
Jul 12
2024
|
Valerie Morisset EVP, R&D AND CSO |
SELL
Open market or private sale
|
Direct |
50,000
-14.51%
|
$350,000
$7.07 P/Share
|
|
Jul 11
2024
|
Valerie Morisset EVP, R&D AND CSO |
SELL
Open market or private sale
|
Direct |
50,000
-12.67%
|
$350,000
$7.11 P/Share
|
|
Jul 10
2024
|
Valerie Morisset EVP, R&D AND CSO |
SELL
Open market or private sale
|
Direct |
50,000
-11.24%
|
$300,000
$6.83 P/Share
|
|
Jul 09
2024
|
Valerie Morisset EVP, R&D AND CSO |
SELL
Open market or private sale
|
Direct |
5,931
-1.32%
|
$35,586
$6.66 P/Share
|
|
Jul 05
2024
|
Valerie Morisset EVP, R&D AND CSO |
SELL
Open market or private sale
|
Direct |
12,342
-2.67%
|
$86,394
$7.06 P/Share
|
|
Jul 03
2024
|
Valerie Morisset EVP, R&D AND CSO |
SELL
Open market or private sale
|
Direct |
50,000
-9.75%
|
$300,000
$6.76 P/Share
|
|
Jul 01
2024
|
Valerie Morisset EVP, R&D AND CSO |
BUY
Exercise of conversion of derivative security
|
Direct |
7,649
+1.47%
|
-
|